top of page
"Frontier Bio is doing more than just creating lab-grown human tissues. They're paving the way for a future where organ donors are no longer needed, and animal testing is a thing of the past."
George Church
​​
Scientific Advisor
The Time is Now
"The FDA Modernization Act 2.0, signed by President Biden, allows clinical trial leaders to use animal trial alternatives instead of traditional animal modeling for drug and biological development."
- Veronica Salib, Pharma News Intelligence
​
Read more about it in The Pharma Letter and the New York Times
In Partnership With / Supported By
bottom of page